Insider Transactions in Q1 2023 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
18,072
-80.62%
|
$3,614,400
$200.0 P/Share
|
|
Mar 03
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.59%
|
$480,000
$96.45 P/Share
|
|
Feb 23
2023
|
Dennis A Ausiello Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
Marsha Fanucci Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
Margaret A Hamburg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
David E I Pyott Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
Amy W Schulman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 10
2023
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
38,044
-20.25%
|
$8,179,460
$215.29 P/Share
|
|
Feb 10
2023
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,913
+36.83%
|
$1,947,519
$63.0 P/Share
|
|
Feb 03
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,424
-38.94%
|
$790,944
$231.01 P/Share
|
|
Feb 02
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,601
-8.77%
|
$360,225
$225.94 P/Share
|
|
Feb 02
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct |
1,675
-8.93%
|
$376,875
$225.94 P/Share
|
|
Feb 01
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+50.0%
|
-
|
|
Feb 01
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,175
+50.0%
|
-
|